Chemotherapy-induced peripheral neuropathy: a literature review

Martin, Lelia Gonçalves Rocha; Silva, Maria Denise Pessoa

doi:10.1590/S1679-45082011RW2220

Acessibilidade / Reportar erro

Brasil

Español English

sumário « anterior atual seguinte »

Sumário

Review • EINSEinstein (São Paulo) 9 (4) • Oct-Dec 2011 • https://doi.org/10.1590/S1679-45082011RW2220 copy

Chemotherapy-induced peripheral neuropathy: a literature review

Authorship SCIMAGO INSTITUTIONS RANKINGS

ABSTRACT

Peripheral neuropathy is a common side effect in patients undergoing cancer treatment with chemotherapy. This condition can affect patients in several different ways, interfering in their activities of daily living and autonomy. The present study aimed to review the literature on chemotherapy-induced peripheral neuropathy and its treatment or other possible interventions. The findings reveal that chemotherapy-induced peripheral neuropathy is a common condition that affects patients undergoing treatment with some specific drugs. Besides, several different substances have been used to treat or control this condition, although no significant evidence could be found in these studies.

Keywords:
Peripheral nervous system diseases/chemically induced; Drug therapy/adverse effects

N	Database	Title	Authors	Year	Origin	Type of study	Main themes
1	PUBMED	Persistent mobility disability after neurotoxic chemotherapy	Hile ES, Fitzgerald GK, Studenski SA	2010	United States	Case Study	Clinical manifestations
2	PUBMED	BNP7787-mediated modulation of paclitaxel- and cisplatin-induced aberrant microtubule protein polymerization in vitro	Parker AR, Petluru PN, Wu M, Zhao M, Kochat H, Hausheer FH	2010	United States	Review	Pathophysiology
3	PUBMED	Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat	Carozzi VA, Chiorazzi A, Canta A, Lapidus RG, Slusher BS, Wozniak KM, Cavaletti G	2010	Italy	Experimental	Treatment
4	CINAHL	Radio frequency ablation in drug resistant chemotherapy-induced peripheral neuropathy: a case report and review of literature	Yadav N, Philip FA, Gogia V, Choudhary P, Rana SPS, Mishra S, Bhatnagar B	2010	India	Review	Treatment
5	PUBMED	Patient perceptions associated with chemotherapy-induced peripheral neuropathy	Tofthagen C	2010	United States	Clinical trial	Clinical manifestations
6	WEB OF SCIENCE	Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice	Bruna J, Udina E, Alé A, Vilches JJ, Vynckier A, Monbaliu J, Silverman L, Navarro X	2010	Spain	Experimental	Physiopathology
7	PUBMED	A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA	Barton DL, Wos EJ, Qin R, Mattar BI, Green NB, Lanier KS, Bearden JD, Kugler JW, Hoff KL, Reddy PS, Rowland KM, Riepl M, Christensen B, Loprinzi CL	2010	United States	Clinical trial	Treatment
8	PUBMED	Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies	Gutiérreza GG, Serenoa M, Miralles A, Casado-Sáenz E, Gutiérrez-Rivas E	2010	Spain	Review	Clinical manifestations
9	PUBMED	Animal models of chemotherapy-evoked painful peripheral neuropathies	Authier N, Balayssac D, Marchand F, Ling B, Zangarelli A, Descoeur J, Coudore F, Bourinet E, Eschalier A	2009	France	Review	Treatment
10	PUBMED	Neuropatia inducida por quimioterapia: um problema no resuelto	Velasco R, Bruna J	2009	Spain	Review	Clinical manifestations
11	PUBMED	Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated With Paclitaxel	Reyes-Gibby CC, Morrow PK, Buzdar A, Shete S	2009	United States	Clinical trial	Incidence
12	WEB OF SCIENCE	Therapy of chemotherapy-induced peripheral neuropathy	Kaley TJ, DeAngelis LM	2009	United States	Review	Treatment
13	PUBMED	Compartmentalized microfluidic culture platform to study mechanism of paclitaxel-induced axonal degeneration	Yang IH, Siddique R, Hosmane S, Thakor N, Höke A	2009	United States	Experimental	Pathophysiology
14	PUBMED	Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02	Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Kuroi K, Ohsumi S, Makino H, Mukai H, Katsumata N, Sunada Y, Watanabe T, Hausheer FH	2009	Japan	Clinical trial	Evaluation
15	PUBMED	Prospective assessment of chemotherapy induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)	Kuroi K, Shimozuma K, Ohashi Y, Hisamatsu K, Masuda N, Takeuchi A, Aranishi T, Morita S, Ohsumi S, Hausheer FH	2009	Japan	Clinical trial	Incidence
16	WEB OF SCIENCE	The use of cannabinoids (CBs) for the treatment of chemotherapy-induced peripheral neuropathy (CIPN): A retrospective review	Gingerich J, Wadhwa D, Lemanski L, Krahn M, Daeninck PJ	2009	Canada	Review	Treatment
17	WEB OF SCIENCE	Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia	Ramchandren S, Leonard M, Mody RJ, Donohue JE, Moyer J, Hutchinson R, Gurney JG	2009	United States	Clinical trial	Clinical manifestations
18	PUBMED	Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy	Amara S	2008	United States	Review	Treatment
19	CINAHL	Chemotherapy-induced peripheral neuropathy was described as background noise affecting daily life	Alford M	2008	United States	Clinical trial	Clinical manifestations
20	CINAHL	Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies	Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C	2008	United States	Review	Treatment
21	PUBMED	Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review	De Grandis D	2007	Italy	Review	Treatment
22	PUBMED	Vitamin E for the prevention of CIPN: rationale for an ongoing clinical trial	Kottschade L, Loprinzi C, Rao R	2007	United States	Clinical trial	Treatment
23	PUBMED	Putting evidence into practice®: evidence-based interventions for chemotherapy-induced peripheral neuropathy	Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C	2007	United States	Review	Treatment
24	PUBMED	Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF	Kirchmair R, Tietz AB, Panagiotou E, Walter DH, Silver M, Young-Sup, Yoon Y, Schratzberger P, Weber A, Kusano K, Weinberg DH, Ropper AH, Isner J F, Losordo DW	2007	United States	Clinical trial	Treatment
25	PUBMED	Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy	Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F	2006	United States	Review	Pathophysiology
26	PUBMED	Acupuncture treatment of CIPN – a case series	Wong R, Sagar S	2006	Canada	Case study	Treatment

Instituto Israelita de Ensino e Pesquisa Albert Einstein Avenida Albert Einstein, 627/701 , 05651-901 São Paulo - SP, Tel.: (55 11) 2151 0904 - São Paulo - SP - Brazil
E-mail: revista@einstein.br

Acompanhe os números deste periódico no seu leitor de RSS

[1] Corresponding author: Lelia Gonçalves Rocha Martin – Avenida Albert Einstein, 627/701 – Piso Chinuch – Oncologia ambulatorial de quimioterapia – Morumbi – CEP 05651-901 – São Paulo (SP), Brazil – Tel.: 11 2151-1233 – E-mail: lelia@einstein.br